Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009–2010 season in the active component U.S. military and civilians aged 17–44years reported to the Vaccine Adverse Event Reporting System

التفاصيل البيبلوغرافية
العنوان: Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009–2010 season in the active component U.S. military and civilians aged 17–44years reported to the Vaccine Adverse Event Reporting System
المؤلفون: Renata J.M. Engler, Michael M. McNeil, Susan K. Duderstadt, Barbara H. Bardenheier
المصدر: Vaccine. 34:4406-4414
بيانات النشر: Elsevier BV, 2016.
سنة النشر: 2016
مصطلحات موضوعية: Adult, Male, Adolescent, Guillain-Barre Syndrome, Article, Young Adult, 03 medical and health sciences, Adverse Event Reporting System, Influenza A Virus, H1N1 Subtype, 0302 clinical medicine, 030225 pediatrics, Environmental health, Influenza, Human, Pandemic, Adverse Drug Reaction Reporting Systems, Humans, Live attenuated influenza vaccine, Medicine, 030212 general & internal medicine, Adverse effect, Retrospective Studies, General Veterinary, General Immunology and Microbiology, Behavioral Risk Factor Surveillance System, business.industry, Vaccination, Public Health, Environmental and Occupational Health, United States, Military personnel, Military Personnel, Infectious Diseases, Influenza Vaccines, Immunology, Human mortality from H5N1, Molecular Medicine, Female, business
الوصف: Background No comparative review of Vaccine Adverse Event Reporting System (VAERS) submissions following pandemic influenza A (H1N1) 2009 and seasonal influenza vaccinations during the pandemic season among U.S. military personnel has been published. Methods We compared military vs. civilian adverse event reporting rates. Adverse events (AEs) following vaccination were identified from VAERS for adults aged 17–44 years after pandemic (monovalent influenza [MIV], and seasonal (trivalent inactivated influenza [IIV3], live attenuated influenza [LAIV3]) vaccines. Military vaccination coverage was provided by the Department of Defense’s Defense Medical Surveillance System. Civilian vaccination coverage was estimated using data from the National 2009 H1N1 Flu Survey and the Behavioral Risk Factor Surveillance System survey. Results Vaccination coverage was more than four times higher for MIV and more than twenty times higher for LAIV3 in the military than in the civilian population. The reporting rate of serious AE reports following MIV in service personnel (1.19 per 100,000) was about half that reported by the civilian population (2.45 per 100,000). Conversely, the rate of serious AE reports following LAIV3 among service personnel (1.32 per 100,000) was more than twice that of the civilian population. Although fewer military AEs following MIV were reported overall, the rate of Guillain–Barre Syndrome (GBS) (4.01 per million) was four times greater than that in the civilian population. (1.04 per million). Conclusions Despite higher vaccination coverage in service personnel, the rate of serious AEs following MIV was about half that in civilians. The rate of GBS reported following MIV was higher in the military.
تدمد: 0264-410X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a301e8dd5c907aae34428f8ec751f436Test
https://doi.org/10.1016/j.vaccine.2016.07.019Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....a301e8dd5c907aae34428f8ec751f436
قاعدة البيانات: OpenAIRE